Navigation Links
US FDA Approves 30-Minute Onset of Action for Focalin(R) XR, Bringing Potential Benefits to ADHD Patients During Early Morning Period
Date:11/12/2008

seizures or EEG abnormalities. Difficulties with accommodation and blurring of vision have been reported with stimulant treatment. (See WARNINGS.)

Focalin XR should be given cautiously to patients with a history of drug dependence or alcoholism. Chronic abusive use can lead to marked tolerance and psychological dependence with varying degrees of abnormal behavior. Frank psychotic episodes can occur, especially with parenteral abuse. Careful supervision is required during drug withdrawal from abusive use since severe depression may occur. Withdrawal following chronic therapeutic use may unmask symptoms of the underlying disorder that may require follow-up.

Please see full Prescribing Information for Focalin XR including Contraindications, Boxed Warning and Medication Guide at http://www.FocalinXR.com or call us at 1-888-NOW-NOVA.

For further information, please visit http://www.FocalinXR.com.

Disclaimer

The foregoing release contains forward-looking statements that can be identified by terminology such as "potential," "may," "potentially," "can," or similar expressions, or by express or implied discussions regarding potential additional labeling or indications or potential future sales of Focalin XR. You should not place undue reliance on these statements. Such forward-looking statements reflect the current views of Novartis regarding future events, and involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. There can be no guarantee that Focalin XR will be approved for any additional labeling or indications in any country. Nor can there be any guarantee that Focalin XR will reach any particular sales levels. In particular, management's expectations regarding Focalin XR
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. FDA Approves New Indication for Hospiras Precedex (Dexmedetomidine HCL) Injection
2. Triple-S Management Corporation Reports Third Quarter 2008 Results; Board Approves Share Repurchase Authorization of up to $40 Million
3. Kaiser Permanente Approves $12 Million in Community Benefit Grants in Third Quarter of 2008
4. Congress Sets New Course for Lung Cancer Research; Approves $20 Million for New Defense Department Program
5. FDA Approves Nasacort AQ(R) Nasal Spray for Children Aged 2-5 years old
6. ClearWay Minnesota(SM) Board Approves New Officers
7. FDA approves first drug for Huntingtons disease
8. The California Board of Registered Nursing Approves Affiliations for Nursing Program in Glendale, California
9. Kaiser Permanente Approves $22 Million in Community Benefit Grants in Second Quarter of 2008
10. Hillenbrand, Inc. Board of Directors Approves $100M Share Repurchase Program
11. Edwards Lifesciences Board Approves New $250 Million Share Repurchase Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... May 06, 2015 In March, Dr. ... the 8th Milano Masterclass. As Europe’s most exclusive rhinoplasty ... plastic surgeons. Dr. Batniji was hand chosen to speak ... and Reconstructive Surgery, Dr. Pietro Palma. , The ... The conference hosts a diverse, multi-national faculty; each considered ...
(Date:5/6/2015)... The 2015 STEMtech conference exhibition hall floor plan ... selection . Don’t miss this opportunity to highlight your ... decision-makers from around the country. , This year’s event ... Grand in Phoenix. This beautiful all-suite hotel is nestled ... the South Mountain Preserve. The Phoenix area offers southwestern ...
(Date:5/6/2015)... Norcross, GA (PRWEB) May 06, 2015 ... has chosen Hexagon Geospatial technology to manage and distribute ... , Australia is one of the driest continents on ... supply through times of drought and erratic seasonal rainfalls ... water supply solutions. , Water NSW manages raw water ...
(Date:5/6/2015)... The Florida Council on Compulsive Gambling, Inc. (FCCG), ... Area Geriatric Education Center, Mental Health Association of Southeast ... Substance Abuse, will hold its annual conference in Ft ... Hotel. , This important event will address topics such ... as clinical training for problem gambling treatment services. ...
(Date:5/6/2015)... Hollywood, California (PRWEB) May 06, 2015 ... Avalon Hollywood, Choices Recovery sponsored Durkin Entertainment’s “RockNRolla” ... world’s top providers of products and services that ... by Debbie Durkin, Los Angeles’ leading producer of ... EcoLuxe Lunge is a premier red carpet event ...
Breaking Medicine News(10 mins):Health News:California Surgeon Speaks at International Rhinoplasty Conference 2Health News:STEMtech Conference Exhibitors Gain Access to Community College and University Representatives From Across the U.S. 2Health News:Water NSW Unlocks Imagery and Elevation Data Archive Across the Enterprise using Hexagon Geospatial Solutions 2Health News:Water NSW Unlocks Imagery and Elevation Data Archive Across the Enterprise using Hexagon Geospatial Solutions 3Health News:Conference on Problem Gambling to be held in Ft. Lauderdale, FL 2Health News:Choices Recovery Mishawaka Discusses the Many Forms of Addiction and Treatment with Terrah Bennett Smith 2
... ... be a profitable 2010, the new Wella SP range is set to raise the ... ... hair company in the world, Wella is at the forefront of hairdressing innovation. The introduction ...
... ... struggle to find the balance between investing in the necessary internal resources to implement ... for a dozen online tactics, and identifies where companies are using each tactic in ... ...
... ... of the most common negative patterns in a relationship. Angry individuals may be aware of ... Path.com. , ... (PRWEB) February 1, 2010 -- Personal Power Path announces the launch of an anger management ...
... , Feb. 1 /PRNewswire / -- Ervin Cohen ... announced today that David Bricker , Of Counsel to ... clients last Friday, January 29, 2010 , in a medical malpractice ... Hopp of the Riverside Superior Court and a jury panel of 12. ...
... , BIRMINGHAM, Ala. , Feb. 1 ... Jon P. Stonehouse , President and Chief Executive Officer of BioCryst, plans ... forodesine and BCX4208 at the 12 th Annual BIO CEO ... at 10:30 a.m. Eastern Time . , Links to a ...
... contrast agent gadolinium during magnetic resonance imaging (MRI) for ... metastases, according to a new study published online February ... Institute . Gadolinium-enhanced MRI is primarily used to visualize ... and evaluate lymph node metastases. In light of this ...
Cached Medicine News:Health News:ckwrites.com Releases Report On Creating Online Marketing Tactics 2Health News:Prominent Beverly Hills Law Firm Awarded $16.5 Million Medical Malpractice Jury Verdict 2Health News:Prominent Beverly Hills Law Firm Awarded $16.5 Million Medical Malpractice Jury Verdict 3Health News:BioCryst To Present At 12th Annual BIO CEO & Investor Conference 2Health News:News brief: Contrast agent with MRI improves detection of lymph nodes metastases 2
(Date:5/6/2015)... , May 6, 2015 In ... malaria and tuberculosis combined[1]. Approximately 40 percent of cancer cases ... the right treatment[3]. Together with Elekta, ministries of health in ... their radiation therapy infrastructures and save lives. More ... from radiation therapy[4] during the course of their disease, either ...
(Date:5/6/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/4fgrnh/asiapacific ) ... Internal Trauma Fixation Devices Market by Type & ... report to their offering. The ... to grow at a CAGR of 6.7% from ... rising incidences of road accidents, increasing aging population, ...
(Date:5/6/2015)... GenSpera, Inc. (OTCQB: GNSZ) announced today that the patent ... process in 17 countries and regions, including Europe ... China , Brazil and ... patent application will extend the exclusivity period for GenSpera,s core ... drug candidate, mipsagargin, until 2033. This recent patent ...
Breaking Medicine Technology:Elekta to bring cancer treatment to millions in Africa 2Elekta to bring cancer treatment to millions in Africa 3Elekta to bring cancer treatment to millions in Africa 4Asia-Pacific Internal Trauma Fixation Devices (Internal Trauma Fixation Plates, Screws, Rod Wires & Pins, Fusion Nails) Market 2015 2GenSpera Enters National Phase with Patent Application for Injectable Prodrug Formulations 2
... counterparts when it comes to the consumption of mental health ... as compared to 15 percent of men.  These are findings ... MHS ) that were presented Saturday at the 2012 Women,s ... The study reviewed the pharmacy claims of more ...
... 19, 2012 Ventana Medical Systems, Inc. ( ... is now introducing a novel platform for special ...  Answering customers, challenges with their current process, the ... walk-away automation, baking through staining including deparaffinization, random ...
Cached Medicine Technology:The Mental Health Gender Gap: Women Far Exceed Men in their Use of Psychotropic Medications as Utilization Increases Among Both Sexes 2The Mental Health Gender Gap: Women Far Exceed Men in their Use of Psychotropic Medications as Utilization Increases Among Both Sexes 3Ventana Introduces the BenchMark Special Stains Platform 2Ventana Introduces the BenchMark Special Stains Platform 3
The MC-3 allows for simultaneous use of two lamps, with an additional built-in spare....
Xenon technology achieves a higher efficiency than halogen light sources. Consequently they provide more light....
Delivers one primary lamp and one backup lamp. The port accepts ACMI fiberoptic cables....
A three lamp light source maximizes use by allowing two surgeons to work simultaneously from it, while the third lamp is reserved for backup....
Medicine Products: